CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenues (Note 2)	$ 1,658,000,000	$ 55,000,000	$ 0
Cost of revenues (Note 2)	4,781,000,000	520,000,000	0
Gross profit	(3,123,000,000)	(465,000,000)	0
Operating expenses
Research and development (Note 2)	1,944,000,000	1,850,000,000	766,000,000
Selling, general, and administrative (Note 2)	1,789,000,000	1,242,000,000	255,000,000
Other expenses (Note 2)	0	663,000,000	0
Total operating expenses	3,733,000,000	3,755,000,000	1,021,000,000
Loss from operations	(6,856,000,000)	(4,220,000,000)	(1,021,000,000)
Interest income	193,000,000	3,000,000	10,000,000
Interest expense	(103,000,000)	(29,000,000)	(8,000,000)
Loss on convertible notes, net (Note 7)	0	(441,000,000)	0
Other income (expense), net	18,000,000	(1,000,000)	1,000,000
Loss before income taxes	(6,748,000,000)	(4,688,000,000)	(1,018,000,000)
Provision for income taxes	(4,000,000)	0	0
Net loss	(6,752,000,000)	(4,688,000,000)	(1,018,000,000)
Net loss attributable to common stockholders, basic (in shares)	(6,752,000,000)	(4,688,000,000)	(1,019,000,000)
Net loss attributable to common stockholders, diluted (in shares)	$ (6,752,000,000)	$ (4,688,000,000)	$ (1,019,000,000)
Net loss per share attributable to common stockholders, basic (in USD per share)	$ (7.40)	$ (22.98)	$ (10.09)
Net loss per share attributable to common stockholders, diluted (in USD per share)	$ (7.40)	$ (22.98)	$ (10.09)
Weighted average common shares outstanding - basic (in shares)	913	204	101
Weighted average common shares outstanding - diluted (in shares)	913	204	101